QuickView for CASP-2;jsessionid=5DEB2FCE89368D47002682B883EC5C23;jsessionid=79CD2949A991C82D8C5BAB5026C3A49D;jsessionid=9BA78DF8E319A8ED2DFA32F79AE09B94;jsessionid=7FA9273C7C615BDCF372D2A23BDAC828 (gene)

1. An electrophilic fragment screening for the development of small molecules targeting caspase-2.
2. Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis.
3. Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias.
4. Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Model…
5. Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics.

There were no clinical trials for CASP-2;jsessionid=5DEB2FCE89368D47002682B883EC5C23;jsessionid=79CD2949A991C82D8C5BAB5026C3A49D;jsessionid=9BA78DF8E319A8ED2DFA32F79AE09B94;jsessionid=7FA9273C7C615BDCF372D2A23BDAC828